Press release
Leading Growth Driver in the Nontuberculous Mycobacterial Infection Market in 2025: Rising Prevalence Of Copd Fuels Growth In The Nontuberculous Mycobacterial Infection Market Driver's Influence
What Are the Market Size and Growth Forecast for the Nontuberculous Mycobacterial Infection Market?The nontuberculous mycobacterial infection market has demonstrated strong growth in recent years. It is expected to grow from $14.25 billion in 2024 to $15.11 billion in 2025, at a CAGR of 6.0%. This expansion has been driven by advancements in diagnostic techniques, a growing aging population, increased awareness of cystic fibrosis, and the use of immunosuppressive medications.
The nontuberculous mycobacterial infection market is projected to see strong growth, reaching $19.57 billion by 2029, growing at a CAGR of 6.7%. The growth is driven by antimicrobial drug development, greater awareness of NTM, advances in genetic research, and the adoption of telehealth and remote monitoring. Major trends include personalized treatments, regulatory focus, combination therapies, and digital health tools.
What Is Contributing to the Growth of the Nontuberculous Mycobacterial Infection Market?
The increasing occurrence of chronic obstructive pulmonary disease (COPD) is projected to accelerate the expansion of the nontuberculous mycobacterial infection market. COPD is a persistent respiratory disease that results in progressive airflow limitation in the lungs. Patients with COPD who develop nontuberculous mycobacterial (NTM) infections experience a greater decline in forced expiratory volume in one second (FEV1) and a higher rate of exacerbations. COPD weakens the immune system and causes lung tissue damage, making individuals more susceptible to NTM infections. For example, in March 2023, the Scottish Public Health Observatory (ScotPHO), a Scotland-based public health organization, published a report indicating that COPD rates increased between 2021 and 2022. Among males, the rates rose from 83.2 to 97.6 per 100,000 individuals, while female rates climbed from 72.6 to 97.3 per 100,000. Therefore, the rising prevalence of COPD is propelling the growth of the nontuberculous mycobacterial infection market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13020&type=smp
Which Key Market Leaders Are Driving Nontuberculous Mycobacterial Infection Industry Growth?
Major companies operating in the nontuberculous mycobacterial infection market are Pfizer Inc., Johnson & Johnson, F. Hoffman La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Horizon Therapeutics PLC, Lupin Limited, BioMarin Pharmaceutical Inc., Ionis Pharmaceuticals Inc., Insmed Incorporated, Paratek Pharmaceuticals Inc., Spero Therapeutics Inc., Aradigm Corporation, Dauntless Pharmaceuticals Inc., Validus Pharmaceuticals LLC.
What Are the Emerging Trends in the Nontuberculous Mycobacterial Infection Industry?
Prominent companies in the nontuberculous mycobacterial (NTM) infection market are adopting regulatory strategies, such as Fast Track designation, to expedite drug approval processes and strengthen their market presence. The FDA's Fast Track designation accelerates the development and review of drugs designed to treat serious conditions with unmet medical needs. For example, in July 2022, the U.S. Food and Drug Administration granted Fast Track Designation to NUZYRA for the treatment of NTM lung disease caused by Mycobacterium avium complex (MAC). NUZYRA (omadacycline) is a broad-spectrum antibiotic designed to combat severe bacterial infections, including those resistant to conventional treatments. This designation streamlines the regulatory process, facilitating the rapid development and approval of NUZYRA to address significant unmet medical needs.
What Are the Main Segments in the Nontuberculous Mycobacterial Infection Market?
The nontuberculous mycobacterial infection market covered in this report is segmented -
1) By Drug Class: Macrolides, Rifampin, Aminoglycoside, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Other Routes
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Macrolides: Azithromycin, Clarithromycin
2) By Rifampin: Rifampin, Rifabutin
3) By Aminoglycoside: Amikacin, Streptomycin
4) By Other Drug Classes: Ethambutol, Clofazimine, Linezolid
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/nontuberculous-mycobacterial-infection-global-market-report
Which Geographic Area Leads the Nontuberculous Mycobacterial Infection Market?
North America was the largest region in the nontuberculous mycobacterial infection market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in nontuberculous mycobacterial infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Nontuberculous Mycobacterial Infection Global Market Report?
- Market Size Analysis: Analyze the Nontuberculous Mycobacterial Infection Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Nontuberculous Mycobacterial Infection Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Nontuberculous Mycobacterial Infection Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Nontuberculous Mycobacterial Infection Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13020
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Growth Driver in the Nontuberculous Mycobacterial Infection Market in 2025: Rising Prevalence Of Copd Fuels Growth In The Nontuberculous Mycobacterial Infection Market Driver's Influence here
News-ID: 3853018 • Views: …
More Releases from The Business Research Company

Dental Syringes Market Size Forecast: $4.46 Billion by 2029 | Global Outlook
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Projected Market Size Valuation of the Dental Syringes Market by 2025?
The market for dental syringes has experienced significant expansion in the recent past. It is projected to escalate from $3.35 billion in 2024 to $3.55 billion in 2025, recording a compound annual growth rate (CAGR) of 6.1%.…

Dental Charting Software Industry Expected to Reach $2.71 Billion by 2029 at 12. …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Dental Charting Software Market Value Projection: How Much Will the Market Size by 2025?
The market size for dental charting software has seen a swift expansion in the past few years. It is projected to rise from $1.48 billion in 2024 to $1.67 billion in 2025, reflecting a compound annual growth…

Global Corticosteroid Eyedrops Market Worth $12.88 Billion by 2029, Growing at 6 …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Corticosteroid Eyedrops Market Outlook: What Size And CAGR Are Anticipated By 2025?
In recent times, the corticosteroid eyedrops market has experienced significant growth. It is anticipated that it will expand from $8.36 billion in 2024 to $10.00 billion in 2025, witnessing a compound annual growth rate (CAGR) of 6.8%. …

Global Cancer Treatment Facilities Market Size, Share, and Forecast Analysis 202 …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Cancer Treatment Facilities Market Size Forecast for 2025?
Over the past several years, the cancer treatment facilities market has seen significant expansion. Its growth is projected to increase from $44.63 billion in 2024 to $48.27 billion in 2025, registering an 8.1% compound annual growth rate (CAGR). The…
More Releases for Nontuberculous
Rising Prevalence Of Copd Fuels Growth In The Nontuberculous Mycobacterial Infec …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
What Is the Expected CAGR for the Nontuberculous Mycobacterial Infection Market Through 2025?
There has been a substantial expansion in the market size for nontuberculous mycobacterial infection in the recent past. The market, which is projected to increase from $14.25 billion in 2024 to $15.11 billion in 2025, is…
Rising Prevalence Of Copd Fuels Growth In The Nontuberculous Mycobacterial Infec …
The Nontuberculous Mycobacterial Infection Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Nontuberculous Mycobacterial Infection Market Size and Projected Growth Rate?
The market size for nontuberculous mycobacterial infection has experienced robust growth in the past few years. The market that was valued at…
Nontuberculous Mycobacteria Market Growth and Key Innovations | 2025 To 2034 Sta …
On April 23, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Nontuberculous Mycobacteria Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Nontuberculous Mycobacteria Market Projected to Show Strong Growth
Pro Market Reports published a new research publication on "Nontuberculous Mycobacteria Market" with 230+ pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Nontuberculous Mycobacteria market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in the study are:…
Nontuberculous Mycobacterial Infection Market 2024 - By Size, Industry Analysis, …
The new report published by The Business Research Company, titled Nontuberculous Mycobacterial Infection Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the nontuberculous mycobacterial infection market size has grown strongly in recent years. It will grow from $13.43 billion…
Combating Infection: Nontuberculous Mycobacterial Infection Market Analysis 2024 …
The nontuberculous mycobacterial infection market size has grown strongly in recent years. It will grow from $13.43 billion in 2023 to $14.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to improved diagnostics, aging population, cystic fibrosis awareness, immunosuppressive medications.
The nontuberculous mycobacterial infection market size is expected to see strong growth in the next few…